Isatuximab and Bendamustine in Systemic Light Chain Amyloidosis
Conditions: Amyloidosis; Light Chain (AL) Amyloidosis Interventions: Drug: Bendamustine Hydrochloride; Drug: Isatuximab Sponsors: Tufts Medical Center; Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials